{"classes":[{"categories":[{"measurements":[{"comment":"Upper limit not reached","groupId":"OG000","lowerLimit":"10.7","upperLimit":"NA","value":"13.5"},{"groupId":"OG001","lowerLimit":"13.8","upperLimit":"20.4","value":"16.7"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"79"},{"groupId":"OG001","value":"40"}],"units":"Participants"}],"description":"Overall survival is defined as the time from the date of the first dose of study intervention to the date of death due to any cause.","dispersionType":"95% Confidence Interval","groups":[{"description":"Final Analysis with DCO on 06May2024","id":"OG000","title":"TNBC Cohort"},{"description":"Final Analysis with DCO on 27Nov2024","id":"OG001","title":"NSCLC Cohort"}],"paramType":"MEDIAN","populationDescription":"FAS: Enrolled participants who have received at least one dose of treatment. Participants who were enrolled but did not subsequently receive study intervention are not included in the analysis.","reportingStatus":"POSTED","timeFrame":"TNBC cohort: from enrollment to 13 months post last subject dose with a median of 12 months follow up. NSCLC cohort: from enrollment to 20 months post last subject dose with a median of 16.7 months follow up.","title":"Overall Survival (OS)","type":"SECONDARY","unitOfMeasure":"Month"}